WENZHOU,áChina, June 12, 2018 /PRNewswire/ --áHebron Technology Co., Ltd. ("Hebron" or the "Company") (Nasdaq: HEBT), a developer,manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its strategic business development plan, designed to allow the company to expand from being
As previously disclosed, on March 10, 2018 Hebron acquired 49% of Xuzhou Weijia Biotechnology Co., Ltd., for R&D, sales of health foods, nutritional supplements, and other health related products, and access to distribution channels and relationships with major pharmaceutical and health care related product manufacturers. In addition, as part of its growth plan, management of the Company plans to introduce advanced medical equipment and medical technology as well as invest in healthcare related upstream and downstream companies.
Mr. Anyuan Sun, Chairman and Chief Executive Officer ofáHebron, commented, "While we continue to grow our core business of providing comprehensive process pipeline systems and engineer designs, installations and services for pharmaceutical factories, we also see a great opportunity to expand our market share in the pharmaceutical sector while developing new product and service offerings in other healthcare segments, such as medical equipment, as well as health food and beverage markets."
Mr. Sun continued, "We are excited about the potential of our development plan. We expect that our increased focus on new business initiatives will lead to more innovative and breakthrough product introductions over the coming years. This plan is a significant first step toward creating a portfolio of brands that are laser-focused on the healthcare field and leverages the strengths of our company."
About Hebron Technology Co., Ltd.
Established ináJanuary 2005áand headquartered in Wenzhou City,áZhejiang Province,áChina, Hebron Technology Co., Ltd. ("Hebron" or the "Company") engages in research, development, and manufacture of highly specialized valves and pipe fitting products for use in the pharmaceutical, biological, food and beverage, and other clean industries. The Company also offers its customers comprehensive pipeline design, installation, construction, and ongoing maintenance services as holistic solution services. For more information about the Company, please visit www.xibolun.com.
This press release contains information aboutáHebron'sáview of its future expectations, plans and prospects that constitute forward-looking statements.áActual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business both in legacy and new segments, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property.áHebron encourages you to review other factors that may affect its future results ináHebron'sáregistration statement and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
Hebron Technology Co., Ltd.á Ms. Yingping Chen SecretaryPhone: +86-180-6776-3129
In the United States:
Ascent Investor Relations LLC Ms.áTina XiaoPhone: +1-917-609-0333Email:átina.email@example.com
View original content:http://www.prnewswire.com/news-releases/hebron-technology-co-ltd-announces-plan-to-expand-healthcare-industry-solutions-300664515.html
SOURCE Hebron Technology Co., Ltd.
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All